Your browser doesn't support javascript.
loading
Evaluating the impact of regulatory action on denosumab-induced hypocalcaemia in Japan.
Imatoh, Takuya; Sai, Kimie; Takeyama, Mayu; Segawa, Katsunori; Yamashita, Takanori; Nakashima, Naoki; Kataoka, Yoko; Yokoi, Hideto; Hiramatsu, Tatsuo; Ohe, Kazuhiko; Kimura, Michio; Hori, Katsuhito; Kawakami, Junichi; Saito, Yoshiro.
Afiliación
  • Imatoh T; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Sai K; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Takeyama M; Division of Medicinal Safety Science, National Institute of Health Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Kawasaki, Japan.
  • Segawa K; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
  • Yamashita T; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
  • Nakashima N; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
  • Kataoka Y; Department of Medical Informatics, Kagawa University Hospital, Kagawa, Japan.
  • Yokoi H; Department of Medical Informatics, Kagawa University Hospital, Kagawa, Japan.
  • Hiramatsu T; Department of Medical Informatics and Economics, Division of Social Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
  • Ohe K; Department of Medical Informatics and Economics, Division of Social Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
  • Kimura M; Department of Medical Informatics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Hori K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Saito Y; Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
J Clin Pharm Ther ; 44(5): 788-795, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31282013

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Conservadores de la Densidad Ósea / Denosumab / Hipocalcemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Conservadores de la Densidad Ósea / Denosumab / Hipocalcemia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Japón